Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Saigon Technology Highlights Vietnam's Rapid Growth as a Global Innovation Hub
-
AAM Reports Third Quarter 2025 Financial Results
-
Resolution Therapeutics announces new data showcasing the potential of Regenerative Macrophage Therapy in treating cirrhosis at AASLD 2025
-
Dechra Advances Public Health as Newest Human-Animal Bond Certified Company
-
Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Live
-
Edgewise Therapeutics to Participate in Upcoming Investor Conferences
-
KB Home Announces the Grand Opening of Three New Communities Within the Highly Desirable Tivoli Master Plan in Modesto, California
-
Guardant Health to Participate in Upcoming Investor Conferences
-
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR NOVEMBER 2025
-
'Coffee Diplomacy' at APEC: Korea-U.S. Startup Imunika Goes Viral as Japan's Motegi Prepares Tariff Talks with Trump
-
NAVEE Unveils G5 Series Electric Scooter: A Smarter, Safer, and More Stylish Way to Move Through the City
-
Shop Early, Save Big: Kohl’s Black Friday Savings Start Now
-
LG Innotek Reaffirms World-Leading Automotive Lighting Innovation for Second Consecutive Year
-
Black Friday Starts Early at Curacao: Three Weeks of Massive Savings You Can’t Miss
-
CrowdStrike’s Fal.Con 2026 Takes Over Mandalay Bay and Launches the Day Zero Threat Summit
-
interpark Global Opens Ticket Sales for G-DRAGON's Encore Concert and SBS Gayo Daejeon
-
ACP Completes Growth Capital Investment in Advantage Investigations
-
Strategy Announces Pricing of Initial Public Offering of € Denominated STRE Stock
-
Vor Bio to Participate in Upcoming Investor Conferences
-
ChargePoint CEO Named to 2025 TIME100 Climate List
-
Bit Digital Inc. Reports Monthly Ethereum Treasury and Staking Metrics for October 2025
-
Coreline Soft Unveils AVIEW 2.0 at RSNA 2025: Next-Generation AI Platform Redefining Radiology Workflow Standards
-
Establishment Labs to Present at Jefferies London Healthcare Conference
-
J.W. Roth Named to Billboard’s 2025 Touring Power Players List
-
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow Disease Progression
-
Northern Trust Named Best Private Bank in U.S.
-
Asbury Carbons Announces Price Increases Across All Graphite Product Lines, Cokes, and Non-Carbon Materials
-
nChroma Bio Presents Preclinical Data Demonstrating Epigenetic Silencing Approach as a Potential Functional Cure for Chronic Hepatitis B at AASLD 2025
-
On Veterans Day, Autobell® Car Wash Thanks U.S. Military Veterans and Active-Duty Service Members with Free Ride-Thru Wash
-
Vaxart to Host Upcoming Conference Calls
-
Dupixent® (dupilumab) Pivotal Trial Met All Primary and Secondary Endpoints, Reducing Signs and Symptoms of Allergic Fungal Rhinosinusitis (AFRS); sBLA Accepted for FDA Priority Review
-
Biofrontera Inc. announces sale of license to Xepi® Antibiotic Cream to Pelthos Therapeutics Inc. for up to $10M
-
AirJoule Technologies Schedules Release of Third Quarter 2025 Results and Conference Call
-
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
-
Dycom Industries, Inc. to Host Fiscal 2026 Third Quarter Results Conference Call
-
Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
-
Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ESET to aid MSPs by integrating with ConnectWise Asio
-
Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies
-
Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA pri
-
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting
-
KOPPERS REPORTS THIRD QUARTER 2025 RESULTS
-
ArcadianAI Takes Over Enterprise Video Monitoring: The AI Security Guard Replacing Human Operators and Outdated Software
-
CHIPOTLE HONORS SERVICE MEMBERS WITH A VETERANS DAY ENTRÉE OFFER
-
From Waiting to Taking Action: How XRP Holders Made “$8,500 in Passive Income Per Day” a Reality Through Find Mining
-
Café Noir Faces Unfair Criticism from Online Trolls
-
Eco-Friendly Cleaning Experts Elevate Austin Homes and Businesses
-
Debtors Advocacy Group Announces Attorney-Led Debt Relief Service
-
Alonzo Mourning Shares His Journey to Raise Awareness for Kidney Disease
